Skip to Content
Merck
  • Investigation of synergism with combinations of dibromopropamidine isethionate or propamidine isethionate and polymyxin B.

Investigation of synergism with combinations of dibromopropamidine isethionate or propamidine isethionate and polymyxin B.

The Journal of pharmacy and pharmacology (1994-07-01)
M R Richards, D K Xing
ABSTRACT

Combinations of polymyxin B and dibromopropamidine isethionate exhibited synergistic inhibitory and bactericidal activity against Pseudomonas aeruginosa, Enterobacter cloacae, Proteus mirabilis, Escherichia coli and Staphylococcus aureus. Similar results were obtained with polymyxin B plus propamidine combinations except that propamidine was not as active as dibromopropamidine and the combination of polymyxin B plus propamidine against S. aureus only had additive activity. The antibacterial agents were tested in solutions and in a cream formulation. The findings indicate a potential for the use of selected combinations of these antibacterial agents in the treatment of wound and superficial eye infections.

MATERIALS
Product Number
Brand
Product Description

Dibrompropamidine for system suitability, European Pharmacopoeia (EP) Reference Standard
Dibrompropamidine diisetionate, European Pharmacopoeia (EP) Reference Standard